Cystatin C (CysC) plays diverse protective roles under conditions of neuronal challenge. We investigated whether CysC protects from trisomy-induced pathologies in a mouse model of Down syndrome (DS), the most common cause of developmental cognitive and behavioral impairments in humans. We have previously shown that the segmental trisomy mouse model, Ts[Rb(12.1716)]2Cje (Ts2) has DS-like neuronal and behavioral deficiencies. The current study reveals that transgene-mediated low levels of human CysC overexpression has a preventive effect on numerous neuropathologies in the brains of Ts2 mice, including reducing early and late endosome enlargement in cortical neurons and decreasing loss of basal forebrain cholinergic neurons (BFCNs). Consistent with these cellular benefits, behavioral dysfunctions were also prevented, including deficits in nesting behavior and spatial memory. We determined that the CysC-induced neuroprotective mechanism involves activation of the phosphotidylinositol kinase (PI3K)/AKT pathway. Activating this pathway leads to enhanced clearance of accumulated endosomal substrates, protecting cells from DS-mediated dysfunctions in the endosomal system and, for BFCNs, from neurodegeneration. Our findings suggest that modulation of the PI3/AKT pathway offers novel therapeutic interventions for patients with DS.
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Introduction
DS is a genetic disease caused by trisomy of human chromosome 21 (HSA21), associated with developmental brain abnormalities (Wisniewski et al., 1984) and early intellectual disabilities (Rueda et al., 2012) . DS individuals develop age-related cholinergic degeneration (Casanova et al., 1985; Head et al., 2016) , similar to Alzheimer's disease (AD) patients (Casanova et al., 1985; Holtzman et al., 1992; Yates et al., 1983) , a cause of memory impairments (Browne et al., 2001; Das et al., 2014; Lin et al., 1999; Velazquez et al., 2013) . Mouse models of DS with chromosome 16 (MMU16) segmental trisomy, orthologous to HSA21 (Davisson et al., 1990; Granholm et al., 2000; Holtzman et al., 1996; Villar et al., 2005) have been an important source of information on DSrelated dysfunctions and characteristic phenotypes responsible for DSspecific changes. Previous reports have shown that, similar to DS patients, the trisomic mouse models Ts65Dn (Davisson et al., 1990) and Ts [Rb(12.17 16 )]2Cje (Ts2) (Villar et al., 2005) exhibit progressive degeneration of the cholinergic system (Jiang et al., 2016; Powers et al., 2016; Seo and Isacson, 2005) and further cognitive deficits (Kaur et al., 2014; Powers et al., 2016; Seo and Isacson, 2005) . The DS related characteristic progressive degeneration of the cholinergic system (Fodale et al., 2006) has been attributed to endosomal dysfunctions (Jiang et al., 2016; Salehi et al., 2006; Xu et al., 2016) . While the etiology of DS-related neuronal early endosomal dysfunction is likely to be multifactorial, various studies have shown that triplication of the gene coding for the amyloid-β precursor protein (APP), located on HSA21 (Kang et al., 1987) , that results in the overexpression of APP and APP metabolites, contributes to endosomal disruption in neurons (Cataldo et al., 2001; Choi, 1988; Jiang et al., 2016; Nixon, 2017; Xu et al., 2016) and non-neuronal cells (Jiang et al., 2010) .
Multiple in vitro and in vivo studies have demonstrated that CysC plays protective roles via various pathways that depend upon inhibition of cysteine proteases, induction of cellular autophagy, induction of cell proliferation, or inhibition of Aβ aggregation [reviewed in (Gauthier et al., 2011; Kaur and Levy, 2012; Mathews and Levy, 2016) 
